RDMD | 692 followers on LinkedIn | Accelerating drug research for rare diseases of all kinds | RDMD's mission is to empower patients and communities to accelerate the development of treatments for rare diseases of all kinds. We are a medical data science company that helps to identify patients and generate regulatory-grade evidence to enable drug approvals and real world evidence in rare disease. RDMD is privately funded by Lux Capital and Village Global, a venture capital firm with a network of LPs including Reid Hoffman, Bill Gates, Mark Zuckerberg, and Jeff Bezos.
| Website | http://www.rdmd.com |
| Employees | 8 (8 on RocketReach) |
| Founded | 2017 |
| Industry | Biotechnology, Medical Records Systems, Hospital & Health Care, Enterprise Systems (Healthcare), Design |
| Keywords | Rare Diseases, Drug Research, Accelerated Drug Development, Orphan Drugs, Clinical Trials, Drug Discovery, Clinical Research, New Drug Development, Pharmaceutical Development, Precision Medicine, Pharmaceutical Research, Biotechnology, Patient Advocacy, Therapeutic Development, Biopharma, Medical Research, Life Sciences, Medical Technology, Health Technology |
Looking for a particular AllStripes (formerly RDMD) employee's phone or email?
Caitlin Nichols is the Research Director of AllStripes (formerly RDMD).
8 people are employed at AllStripes (formerly RDMD).
AllStripes (formerly RDMD) is based in San Francisco, California.